Beijing Aosaikang Pharmaceutical Co (SZSE:002755) 3-Year EBITDA Growth Rate : 0.00% (As of Mar. 2024)

View and export this data going back to 2015. Start your Free Trial

What is Beijing Aosaikang Pharmaceutical Co 3-Year EBITDA Growth Rate?

Beijing Aosaikang Pharmaceutical Co's EBITDA per Share for the three months ended in Mar. 2024 was ¥0.03.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

During the past 13 years, the highest 3-Year average EBITDA Per Share Growth Rate of Beijing Aosaikang Pharmaceutical Co was 64.60% per year. The lowest was -26.90% per year. And the median was 1.05% per year.

Competitive Comparison of Beijing Aosaikang Pharmaceutical Co's 3-Year EBITDA Growth Rate

For the Drug Manufacturers - Specialty & Generic subindustry, Beijing Aosaikang Pharmaceutical Co's 3-Year EBITDA Growth Rate, along with its competitors' market caps and 3-Year EBITDA Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Beijing Aosaikang Pharmaceutical Co's 3-Year EBITDA Growth Rate Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Beijing Aosaikang Pharmaceutical Co's 3-Year EBITDA Growth Rate distribution charts can be found below:

* The bar in red indicates where Beijing Aosaikang Pharmaceutical Co's 3-Year EBITDA Growth Rate falls into.

Beijing Aosaikang Pharmaceutical Co 3-Year EBITDA Growth Rate Calculation

This is the 3-year average growth rate of EBITDA per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

Beijing Aosaikang Pharmaceutical Co (SZSE:002755) 3-Year EBITDA Growth Rate Explanation

EBITDA per Share is the amount of Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) per outstanding share of the company's stock.

Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) is what the company earns before it expenses interest, taxes, depreciation and amortization.

Beijing Aosaikang Pharmaceutical Co 3-Year EBITDA Growth Rate Related Terms

Thank you for viewing the detailed overview of Beijing Aosaikang Pharmaceutical Co's 3-Year EBITDA Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.

Beijing Aosaikang Pharmaceutical Co (SZSE:002755) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Beijing Aosaikang Pharmaceutical Co Ltd (SZSE:002755) » Definitions » 3-Year EBITDA Growth Rate

Traded in Other Exchanges

N/A

Address

South Fourth Ring Road, Building 28 , 7th District, No. 188, Fengtai District, Beijing, CHN, 100070

Website

http://www.bnec.cn

Beijing Aosaikang Pharmaceutical Co Ltd is engaged in the research and development of domestic high-end first imitation drugs, chemical drugs, and biological drugs. Its products focus on digestion, tumors, drug-resistant infections, and chronic diseases.

Executives

Wang Zheng Yong	Executives
Li Xiao Xin	Supervisors
Ren Wei Rong	Directors, executives
Chen Qing Cai	Directors, Directors, and Executives
Du Chao Yang	Executives
Ma Yao Chuan	Director
Wu Zhan Feng	Supervisors
Guo Hong Jie	Director

Beijing Aosaikang Pharmaceutical Co (SZSE:002755) Headlines

No Headlines